# Novel Risk Prediction Approaches for the Primary Prevention of Cardiovascular Diseases in Italy: the CVRISK-IT Trial (CVRISK-IT)

> **NCT06832644** · NA · RECRUITING · sponsor: **IRCCS Policlinico S. Donato** · enrollment: 30000 (estimated)

## Conditions studied

- Cardiovascular Risk
- Genetic Cardiovascular Risk

## Interventions

- **BEHAVIORAL:** Lifestyle Management

## Key facts

- **NCT ID:** NCT06832644
- **Lead sponsor:** IRCCS Policlinico S. Donato
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-22
- **Primary completion:** 2028-01-01
- **Final completion:** 2030-01-01
- **Target enrollment:** 30000 (ESTIMATED)
- **Last updated:** 2026-01-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06832644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06832644, "Novel Risk Prediction Approaches for the Primary Prevention of Cardiovascular Diseases in Italy: the CVRISK-IT Trial (CVRISK-IT)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06832644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*